On the 26th of June an interview with the CEO of F1 Pharma has featured on Biotechnologia.pl portal.
In an interview entitled „A diffused potential turned into a commercial success”, the CEO of F1 Pharma, Mirosław Strózik, PhD, describes the origins of the company, its current offer and strategy, and gives a close-up on the company's plans for the future and explains its advantages over its competitors.
Biotechnologia.pl: We are now in June 2013, so it's been some time since the establishment of the company. How would you summarize the first years of its operation?
Mirosław Strózik: It was in fact a new experience for all of us. Obviously we all have experience in the pharmaceutical business, some even over 10 years, however to turn that into your own private business and to maintain it is a completely different issue. From the perspective of the first three years of operation, I can honestly say that the company has dealt with the difficult first phase of its existence, and is currently a recognisable brand in the pharmaceutical field. We have our regular clients, we have regular orders, and we are constantly looking for new projects and challenges. We are trying to develop in order to keep up with the changes and trends which characterise the market we operate on, and the technology we use. I believe that at the moment everything is heading in the right direction.
The entire interview is available here.